Edition:
United States

John Miller

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

May 16 2018

Novartis top lawyer exits over Trump attorney deal 'mistake'

ZURICH Novartis's top lawyer quit on Wednesday over a $1.2 million contract he co-signed with U.S. President Donald Trump's personal attorney, a deal the Swiss drugmaker's ex-CEO also said was a mistake. | Video

May 16 2018

Novartis ex-CEO says regrets hiring, not firing Trump lawyer

ZURICH Ex-Novartis Chief Executive Joe Jimenez regrets rushing into a $100,000-per-month consulting contract with U.S. President Donald Trump's personal lawyer but said post-election uncertainty over the administration's healthcare ideas put pressure on the Swiss drugmaker to sign a deal quickly.

May 16 2018

Novartis ex-CEO says regrets hiring, not firing Trump lawyer

ZURICH Ex-Novartis Chief Executive Joe Jimenez regrets rushing into a $100,000-per-month (74,280 pounds) consulting contract with U.S. President Donald Trump's personal lawyer but said post-election uncertainty over the administration's healthcare ideas put pressure on the Swiss drugmaker to sign a deal quickly.

May 11 2018

Sika's deal with France's Saint-Gobain may make it a bid target

PARIS/ZURICH Swiss adhesives maker Sika has repelled a hostile takeover bid from Saint-Gobain in a $3.2 billion deal that gives the French company a minority stake but may make Sika a more attractive target for others.

May 10 2018

Companies detail payments to Trump lawyer; Daniels' attorney says there's more

WASHINGTON/ZURICH An attorney for porn star Stormy Daniels said he has additional evidence linking a Russian businessman to U.S. President Donald Trump's personal lawyer, Michael Cohen, as international and U.S. companies on Wednesday acknowledged large payments to Cohen's consulting firm. | Video

May 10 2018

'This is taking an awfully long time!', says scientist before assisted suicide

BASEL A 104-year-old Australian scientist killed himself in Switzerland on Thursday by lethal injection in an assisted suicide he hoped would trigger more lenient euthanasia laws in his home country. | Video

May 10 2018

Setback to Roche hopes for Tecentriq as fails key cancer trial

ZURICH Roche's hopes of its Tecentriq immunotherapy catching rival medicines from Merck and Bristol-Myers Squibb were dealt a blow on Thursday after it failed a key combination trial.

May 09 2018

Novartis calls $1.2 million deal with Trump lawyer's firm a 'mistake'

ZURICH Novartis confirmed it had a $1.2 million contract with the firm of Michael Cohen, U.S. President Donald Trump's personal lawyer, adding it soon realized it had made a mistake but had not been able to stop payments until the deal ended.

May 08 2018

Swiss Islamic leader, facing propaganda charges, refused gun permit

ZURICH A man charged last year with promoting al Qaeda propaganda has been refused a firearms permit, in a ruling by Switzerland's highest court which he said was driven by anti-Muslim discrimination.

Apr 26 2018

Biosimilar worries takes shine off Roche's guidance hike

ZURICH Cheaper copies of Roche's Rituxan toppled the blood cancer drug from its perch as the Swiss company's top seller in the first quarter, unsettling some investors despite a stronger-than-expected performance from new medicines.

Markets

  • U.S.
  • Europe
  • Asia
  • Sectors

Sector Summary